All Stories

  1. Clinical and cost-effectiveness of communication skills e-learning for primary care practitioners on patients’ musculoskeletal pain and enablement: the Talking in Primary care (TIP) cluster-randomised controlled trial
  2. Identifying children who develop severe chronic kidney disease using primary care records
  3. Amitriptyline for the prevention of post herpetic neuralgia: study protocol for the ATHENA study
  4. Predictors of response to low-dose amitriptyline for irritable bowel syndrome and efficacy and tolerability according to subtype: post hoc analyses from the ATLANTIS trial
  5. The Eczema Bathing Study: Weekly versus daily bathing for people with eczema? Protocol of an online, randomised controlled trial
  6. Improving the diagnostic accuracy of referrals for papilloedema (DIPP) study: protocol for a mixed-methods study
  7. Rapid microbiological respiratory point-of-care testing: a qualitative study with primary care clinicians
  8. Food Allergy Test‐Guided Dietary Advice for Children With Atopic Dermatitis: A Consensus Study
  9. Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT
  10. Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCT
  11. Capturing and reporting topical treatment use in childhood eczema: lessons for data collection in eczema trials
  12. ‘Everyone has heard of it, but no one knows what it is’: a qualitative study of patient understandings and experiences of herpes zoster
  13. Emollient application from birth to prevent eczema in high-risk children: the BEEP RCT
  14. Rapid respiratory microbiological point-of-care-testing and antibiotic prescribing in primary care: Protocol for the RAPID-TEST randomised controlled trial
  15. Education to improve timeliness of shingles diagnosis in primary care: a cluster randomised study within a trial with nested qualitative study
  16. Perspectives of Community Pharmacy Staff on Commonly Encountered Skin Conditions and the Key Challenges Towards Enhancing Their Role in Dermatology
  17. Lower urinary tract symptoms in men: the TRIUMPH cluster RCT
  18. Talking in primary care (TIP): protocol for a cluster-randomised controlled trial in UK primary care to assess clinical and cost-effectiveness of communication skills e-learning for practitioners on patients’ musculoskeletal pain and enablement
  19. Online behavioural interventions for children and young people with eczema: a quantitative evaluation
  20. Cost-effectiveness of two online interventions supporting self-care for eczema for parents/carers and young people
  21. Cost-effectiveness of a primary healthcare intervention to treat male lower urinary tract symptoms: the TRIUMPH cluster randomised controlled trial
  22. How can community pharmacists be supported to manage skin conditions? A multistage stakeholder research prioritisation exercise
  23. Atopic eczema in primary care: evidence update and implications for practice
  24. Parent satisfaction with lotion, cream, gel and ointment emollient types: secondary analysis of the Best Emollients for Eczema study
  25. Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trial
  26. Treatment of lower urinary tract symptoms in men in primary care using a conservative intervention: cluster randomised controlled trial
  27. Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial
  28. "not one size fits all” The challenges of measuring paediatric health-related quality of life and the potential role of digital ecological momentary assessment: a qualitative study
  29. Comparison of lotions, creams, gels and ointments for the treatment of childhood eczema: the BEE RCT
  30. Emollients for preventing atopic eczema: Cost‐effectiveness analysis of the BEEP trial
  31. Ideas, concerns, expectations, and effects on life (ICEE) in GP consultations: an observational study using video-recorded UK consultations
  32. Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial
  33. Do temperature changes cause eczema flares? An English cohort study
  34. How and what adverse events are reported and captured in randomized control trials of emollients in the treatment of eczema?
  35. Where and How Have Written Action Plans for Atopic Eczema/Dermatitis Been Developed and Evaluated? Systematic Review
  36. Eczema Care Online behavioural interventions to support self-care for children and young people: two independent, pragmatic, randomised controlled trials
  37. ‘Eczema shouldn’t control you; you should control eczema’: qualitative process evaluation of online behavioural interventions to support young people and parents/carers of children with eczema
  38. Emollients for prevention of atopic dermatitis: 5‐year findings from the BEEP randomized trial
  39. A mixed methods systematic review of digital interventions to support the psychological health and well-being of people living with dermatological conditions
  40. Emollient prescribing formularies and guidelines in England, 2021: a cross-sectional study
  41. Effectiveness and safety of lotion, cream, gel, and ointment emollients for childhood eczema: a pragmatic, randomised, phase 4, superiority trial
  42. Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care
  43. Emollient satisfaction questionnaire: validation study in children with eczema
  44. Detection and management of milk allergy: Delphi consensus study
  45. How parents and children evaluate emollients for childhood eczema: a qualitative study
  46. Eczema Care Online: development and qualitative optimisation of an online behavioural intervention to support self-management in young people with eczema
  47. Reply to correspondence of Martin et al
  48. Strategies for using topical corticosteroids in children and adults with eczema
  49. Burns with emollients
  50. Supporting families managing childhood eczema: developing and optimising eczema care online using qualitative research
  51. Qualitative Assessment of the Conservative Management of Nocturia with Standardised Written Materials for Lower Urinary Tract Symptoms in Men Treated in Primary Care
  52. Test‐guided dietary exclusions for treating established atopic dermatitis in children: A systematic review
  53. Frequency of guideline‐defined cow's milk allergy symptoms in infants: Secondary analysis of EAT trial data
  54. Validation of the RECap of AtoPic eczema measure of eczema control for use in dermatology clinics
  55. Dietary management of patients with eczema: Cross‐sectional survey of dietitians in the United Kingdom
  56. Effective management of male lower urinary tract symptoms in primary care
  57. Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women
  58. Identifying key priorities for research to protect the consumer with food hypersensitivity: A UK Food Standards Agency Priority Setting Exercise
  59. Safety of topical corticosteroids in atopic eczema: an umbrella review
  60. Factors affecting the documentation of spoken safety-netting advice in routine GP consultations: a cross-sectional study
  61. Do Patient Characteristics Matter When Calculating Sample Size for Eczema Clinical Trials?
  62. Healthcare professionals’ beliefs and practices regarding food allergy testing for children with eczema
  63. Assessing the validity, responsiveness and reliability of the Recap measure of eczema control
  64. Supporting self-care for eczema: protocol for two randomised controlled trials of ECO (Eczema Care Online) interventions for young people and parents/carers
  65. Incidence, healthcare-seeking behaviours, antibiotic use and natural history of common infection syndromes in England: results from the Bug Watch community cohort study
  66. Engaging with diverse audiences to raise awareness about childhood eczema: reflections from two community events
  67. Test‐guided dietary management of eczema in children: A randomized controlled feasibility trial (TEST)
  68. Parents and GPs’ understandings and beliefs about food allergy testing in children with eczema: qualitative interview study within the Trial of Eczema allergy Screening Tests (TEST) feasibility trial
  69. Comparing the quantity and quality of randomised placebo-controlled trials of antibiotics for acute respiratory, urinary, and skin and soft tissue infections: a scoping review
  70. The content and conduct of GP consultations for dermatology problems: a cross-sectional study
  71. Views and experiences of managing eczema: systematic review and thematic synthesis of qualitative studies*
  72. Assessing uptake of the Harmonising Outcome Measures for Eczema (HOME) Core Outcome Set and recommended instruments
  73. Would primary care paediatricians improve UK child health outcomes? No
  74. Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial
  75. Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema ( RECAP )
  76. Barriers and enablers to collaborative working between GPs and pharmacists: a qualitative interview study
  77. Development of a tool for coding safety-netting behaviours in primary care: a mixed-methods study using existing UK consultation recordings
  78. Safety netting in routine primary care consultations: an observational study using video-recorded UK consultations
  79. Best emollients for eczema (BEE) – comparing four types of emollients in children with eczema: protocol for randomised trial and nested qualitative study
  80. Which emollients are effective and acceptable for eczema in children?
  81. TReatIng Urinary symptoms in Men in Primary Healthcare using non-pharmacological and non-surgical interventions (TRIUMPH) compared with usual care: study protocol for a cluster randomised controlled trial
  82. Different strategies for using topical corticosteroids in people with eczema
  83. Symptom reporting, healthcare-seeking behaviour and antibiotic use for common infections: protocol for Bug Watch, a prospective community cohort study
  84. TEST (Trial of Eczema allergy Screening Tests): protocol for feasibility randomised controlled trial of allergy tests in children with eczema, including economic scoping and nested qualitative study
  85. Beliefs and practices among adults with eczema and carers of children with eczema regarding the role of food allergy
  86. Adverse Events from Emollient Use in Eczema: A Restricted Review of Published Data
  87. Efficiency versus thoroughness in medication review: a qualitative interview study in UK primary care
  88. Associations between physical activity and asthma, eczema and obesity in children aged 12–16: an observational cohort study
  89. Adaption and validation of the Working Alliance Inventory for General Practice: qualitative review and cross-sectional surveys
  90. Feasibility of weekly participant-reported data collection in a pragmatic randomised controlled trial in primary care: experiences from the BATHE trial (Bath Additives for the Treatment of cHildhood Eczema)
  91. Adding emollient bath additives to standard eczema management for children with eczema: the BATHE RCT
  92. Books: The Itchy-saurus: the Dino with an Itch That Can’t Be Scratched
  93. Comparison of patient (POEM), observer (EASI, SASSAD, TIS) and corneometry measures of emollient effectiveness in children with eczema: findings from the COMET feasibility trial
  94. Emollient prescribing formularies in England and Wales: a cross-sectional study
  95. Emollient bath additives for the treatment of childhood eczema (BATHE): multicentre pragmatic parallel group randomised controlled trial of clinical and cost effectiveness
  96. GP and parent dissonance about the assessment and treatment of childhood eczema in primary care: a qualitative study
  97. GPs’ experiences of diagnosing and managing childhood eczema: a qualitative study in primary care
  98. Written action plans for children with long-term conditions: A systematic review and synthesis of qualitative data
  99. Developing a written action plan for children with eczema: a qualitative study
  100. Impact of a deferred recruitment model in a randomised controlled trial in primary care (CREAM study)
  101. Systematic review of self-management interventions for people with eczema
  102. Effectiveness and cost-effectiveness of daily all-over-body application of emollient during the first year of life for preventing atopic eczema in high-risk children (The BEEP trial): protocol for a randomised controlled trial
  103. Diagnosis, assessment, and treatment of childhood eczema in primary care: cross-sectional study
  104. The ‘One in a Million’ study: creating a database of UK primary care consultations
  105. Oral and Topical Antibiotics for Clinically Infected Eczema in Children: A Pragmatic Randomized Controlled Trial in Ambulatory Care
  106. How do carers and children with eczema choose their emollient?
  107. The management of acne in primary care
  108. Exceeding the recruitment target in a primary care paediatric trial: an evaluation of the Choice of Moisturiser for Eczema Treatment (COMET) feasibility randomised controlled trial
  109. Choice of Moisturiser for Eczema Treatment (COMET): feasibility study of a randomised controlled parallel group trial in children recruited from primary care
  110. Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review
  111. Can continuity of primary care decrease emergency care use? A nested case-control study
  112. Medical undergraduate primary care teaching across the UK: what is being taught?
  113. Ineffective consultations for acne: what is important to patients?
  114. The Patient-Oriented Eczema Measure in young children: responsiveness and minimal clinically important difference
  115. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)
  116. A randomised placebo-controlled trial of oral and topical antibiotics for children with clinically infected eczema in the community: the ChildRen with Eczema, Antibiotic Management (CREAM) study
  117. A practical application of a novel software solution to aid identification of research participants in primary care - the CREAM study (children with eczema antibiotic management study)
  118. The impact of a delayed consent model on trial recruitment - the cream study (children with eczema antibiotic management study)
  119. Using existing trial data to inform the development of core outcome sets and improve efficiencies in research
  120. Bath additives for the treatment of childhood eczema (BATHE): protocol for multicentre parallel group randomised trial
  121. Rapid diagnostic pathways for suspected colorectal cancer: views of primary and secondary care clinicians on challenges and their potential solutions
  122. Decisions, choice and shared decision making in antenatal clinics: An observational study
  123. Depth of the patient–doctor relationship and content of general practice consultations: cross-sectional study
  124. Choice of Moisturiser for Eczema Treatment (COMET): study protocol for a randomized controlled trial
  125. Identifying acne treatment uncertainties via a James Lind Alliance Priority Setting Partnership
  126. Diagnostic Intervals and Its Association with Breast, Prostate, Lung and Colorectal Cancer Survival in England: Historical Cohort Study Using the Clinical Practice Research Datalink
  127. Patient–doctor continuity and diagnosis of cancer: electronic medical records study in general practice
  128. Access to primary care affects the health of Deaf people
  129. The current health of the signing Deaf community in the UK compared with the general population: a cross-sectional study
  130. Predictors of dizziness in older persons: a 10-year prospective cohort study in the community
  131. Complex consultations in primary care: a tool for assessing the range of health problems and issues addressed in general practice consultations
  132. The content of general practice consultations: cross-sectional study based on video recordings
  133. Products in "Bounty bags" potentially harm newborn skin
  134. The Eczema Priority Setting Partnership: a collaboration between patients, carers, clinicians and researchers to identify and prioritize important research questions for the treatment of eczema
  135. Detection of patient psychological distress and longitudinal patient–doctor relationships: a cross-sectional study
  136. Transforming the Perceptual Situation: a Meta-ethnography of qualitative Work Reporting Patients’ Experiences of Mindfulness-Based Approaches
  137. Emollients, education and quality of life: the RCPCH care pathway for children with eczema
  138. Patient-Doctor Depth-of-Relationship Scale: Development and Validation
  139. Dermatology research in primary care: why, what, and how?
  140. Professional experience guides opioid prescribing for chronic joint pain in primary care
  141. Exazerbation des atopischen Ekzems bei Kindern
  142. Exacerbation of atopic eczema in children
  143. How should continuity of care in primary health care be assessed?
  144. The patient–doctor relationship: a synthesis of the qualitative literature on patients' perspectives
  145. “Medication career” or “Moral career”? The two sides of managing antidepressants: A meta-ethnography of patients' experience of antidepressants
  146. 'Two sides of the coin'--the value of personal continuity to GPs: a qualitative interview study
  147. Five futures for academic medicine
  148. Academic medicine has pitfalls for junior researchers
  149. Aminosalicylate monitoring in primary care: an audit and protocol